Lanacordin Pediátrico (Digoxin)

Digoxin inhibits the Na⁺/K⁺‑ATPase pump on heart muscle cells, raising intracellular sodium. This reduces the sodium‑calcium exchanger activity, leading to increased calcium inside the cells. The extra calcium strengthens heart contractions (positive inotropic effect) and prolongs AV‑node refractory period, slowing electrical conduction and reducing heart rate.

The appropriate dose of Lanacordin Pediátrico is determined by the prescribing clinician based on the patient’s age, weight, renal function, electrolyte status and therapeutic response. Dosage regimens are individualized and must follow the prescriber’s instructions and local clinical guidelines.

Digoxin is classified as Pregnancy Category C, indicating that risk to the fetus cannot be ruled out and the drug should be used only if the potential benefit justifies the potential risk. Limited data are available for breastfeeding, and a decision should be made by the healthcare provider after weighing benefits and risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Lanacordin Pediátrico. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Digoxin provides a unique positive inotropic effect and rate‑control property that differs from ACE inhibitors, beta‑blockers or diuretics, which mainly modify neuro‑hormonal pathways or fluid balance. It is often used as an adjunct when additional contractile support or ventricular rate control is required, but it does not replace first‑line guideline‑directed therapies.

Lanacordin Pediátrico should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat. Ensure the container is tightly closed to maintain stability and protect from humidity.

The medication is taken orally, usually as a tablet or liquid preparation, according to the prescriber’s directions. It may be taken with or without food, but consistency with respect to meals helps maintain stable absorption. Patients should follow the exact dosing schedule provided by their healthcare professional.

The most serious risks include cardiac arrhythmias such as ventricular tachycardia, severe bradycardia, and AV block, which can be life‑threatening. Signs of toxicity—nausea, vomiting, visual disturbances, confusion, or irregular heartbeat—should prompt immediate medical evaluation.

Lanacordin Pediátrico is contraindicated in patients with known hypersensitivity to digoxin or other cardiac glycosides, those with uncontrolled ventricular arrhythmias, and individuals with severe renal impairment without dose adjustment. Caution is also advised for patients with electrolyte imbalances, especially low potassium or magnesium.